SCHEDULE: ARK Investment Management Discloses 5.68% Stake in Veracyte
Beneficial Ownership Disclosure
ARK Investment Management LLC and Catherine D. Wood have disclosed a combined beneficial ownership of 5.68% in Veracyte, Inc. common stock.
Summary
- ARK Investment Management LLC and Catherine D. Wood jointly reported beneficial ownership of 4,465,775 shares of Veracyte, Inc. Common Stock.
- This aggregate amount represents 5.68% of Veracyte, Inc.'s outstanding common stock.
- The filing was made under Schedule 13G, indicating passive investment intent.
- ARK Investment Management LLC holds sole voting power over 4,275,350 shares and sole dispositive power over 4,465,775 shares.
- Catherine D. Wood holds shared voting power over 4,360,922 shares and shared dispositive power over 4,465,775 shares.
- The reporting persons' principal business office is located at 200 Central Avenue, St. Petersburg, FL 33701.
Sentiment
Score: 5
Explanation: This is a neutral, factual disclosure of beneficial ownership, not containing performance or operational updates.
Future Outlook
This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from the issuer or the reporting persons regarding the issuer's future performance.
Industry Context
The disclosure of a significant stake by a prominent investment firm like ARK Investment Management, known for its focus on disruptive innovation, can signal institutional interest in Veracyte, a company operating in the diagnostics and precision medicine sector. Such filings are common for active investment managers who cross the 5% ownership threshold.
Stakeholder Impact
- Shareholders: Increased transparency regarding significant institutional ownership, potentially influencing market perception and trading activity.
- Company Management: Awareness of a substantial shareholder, which could lead to engagement on strategic matters, though the filing indicates passive intent.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event requiring the filing of this statement (beneficial ownership reporting date). |
| 11/04/2025 | Signature date for ARK Investment Management LLC and Catherine D. Wood. |
Keywords
Veracyte, ARK Investment Management, Catherine D. Wood, Beneficial Ownership, Schedule 13G, Common Stock, Investment Adviser, Biotechnology, Diagnostics
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.